Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 6Phase 1/2 3Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 17Head & Neck 9Gastrointestinal 8Genitourinary 4Breast 4Sarcoma 3Gynecologic 2Dermatologic 2Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Endocrine 1CNS 1

Conditions

Hematologic Neoplasms 1

Interventions

Cyclophosphamide 34Cytarabine 33Exercise 25Blood Specimen Collection 24venetoclax 23fludarabine phosphate 22Busulfan 22fludarabine 18Methotrexate 18Methods 18Cyclosporine 18Peripheral Blood Stem Cell Transplantation 17Filgrastim 17Antilymphocyte Serum 17Standard of Care 16Whole-Body Irradiation 15Granulocyte Colony-Stimulating Factor 15Educational Status 15Early Intervention, Educational 15Palliative Care 14Melphalan 14Daunorubicin 14Mycophenolic Acid 13Azacitidine 13Practice Guidelines as Topic 12Etoposide 12Dexamethasone 12Radiotherapy 11Vincristine 9Therapeutics 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × X-Rays × Other hematologic neoplasm × Clear all
NCT05600556 2025-05-15

Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

Thomas Jefferson University

Phase NA Withdrawn
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡